symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
MSCLF,0.29025,0.582216,6910,32737878,0,0.116-0.67,-0.0297,Satellos Bioscience Inc.,USD,0001421642,,,Other OTC,PNK,Biotechnology,https://satellos.com,"Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",Mr. Francis  Gleeson B.B.A. M.B.A,Healthcare,CA,,647 660 1780,65 Front Street East,Toronto,ON,M5E 1B5,,0,https://financialmodelingprep.com/image-stock/MSCLF.png,2012-08-03,True,False,True,False,False
